Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro
$ 33.00 · 4.7 (265) · In stock
A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.
Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro
St. John's Nutrition
RikiLeaks
In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect
Cape Town Farmacy
Frontiers Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective
Frontiers A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment
Green Artemisia Annua Plant at Rs 25/piece in Ghaziabad, artemisia annua
Covid-19 protocol
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect